Made to your greatest good results at Mixed Martial Arts is our MMA office in Clinton, Maryland. After you phase into our office, you’ll quickly realize that this is certainly no ordinary mixed martial arts academy, but is something genuinely exceptional.
NRG Energy, Inc. (NYSE:NRG), NRG Yield, Inc. (NYSE: NYLD), and SunPower Corp. (NASDAQ: SPWR) today announced the completion of the final phase of the California Valley Solar Ranch (CVSR) photovoltaic (PV) generating facility in San Luis Obispo County, California, bringing total electric generating capacity of the plant up to 250 megawatts (AC). NRG acquired CVSR from SunPower in 2011, and the project is jointly owned by NRG Yield (48.95%). CVSR is one of the world’s largest operating solar PV power plants and will sell its electricity to Pacific Gas & Electric under two long-term power purchase agreements.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64118-sunpower-nrg-energy-begin-commercial-operations-250-mw-calif-solar-ranch
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
Fluke Corporation, the global leader in portable electronic test and measurement technology, announces the availability of the Fluke® 430 Series II Three Phase Power Analyzers, the first tools to use a patented algorithm to measure energy wasted by power quality issues and quantify its cost. By providing the ROI data needed to justify power quality improvements, the 430 Series II helps facilities reduce electrical power consumption and improve the performance and lifespan of electro-mechanical equipment.
To view Multimedia News Release, go to MNR http://www.multivu.com/mnr/54283-fluke-435-three-phase-power-quality-analyzer-test-generators-motors
Taj Hotels Resorts & Palaces today announced the second phase of their brand architecture exercise with the roll-over of 19 hotels to their new brand, Vivanta by Taj Hotels & Resorts, slotted in the 5-Star Upper Upscale segment. India’s largest hospitality group flagged off Vivanta by Taj Hotels & Resorts at a gala event at the brand’s marquee hotel, Vivanta by Taj – Whitefield, Bangalore. This follows the highly successful launch of their Upscale brand - The Gateway Hotel - exactly two years ago.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/ihc/44198/
Bacardi Limited, the largest privately held spirits company in the world, today announced the initial phase of its US$250 million dollar investment in Scotch whisky production has been completed. This investment is to meet growing demand for the premium portfolio of Dewar’s Scotch whiskies, which are among the top-selling, favorite and most awarded Scotches in the world.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bacardi/46020/
BlackRock, Inc. (NYSE: BLK) today announced that its iShares® Exchange Traded Funds (ETFs) business, the world’s largest manager of ETFs, is launching a campaign to assist investors in learning what to look for when selecting an ETF. The initial phase of the campaign is the publication of an Investor ETF Checklist and an accompanying educational video, both available on the iShares website.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/iShares/47109/
The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children. The study is being performed in conjunction with Children’s Memorial Hermann Hospital, UTHealth’s primary children’s teaching hospital.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cordblood/48021/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Baha Mar celebrated the commencement of construction with its official groundbreaking ceremony on Feb. 21, 2011. The largest single-phase resort development in the history of the Caribbean, the 1,000-acre, $3.4 billion resort, gaming and entertainment complex is slated to open in late 2014, and will include some of the world’s most famous hotel brands, setting a new standard of luxury for the hospitality industry.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bahamar/48767/
